BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19141613)

  • 1. Surface accessibility and conformational changes in the N-terminal domain of type I inositol trisphosphate receptors: studies using cysteine substitution mutagenesis.
    Anyatonwu G; Joseph SK
    J Biol Chem; 2009 Mar; 284(12):8093-102. PubMed ID: 19141613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-dependent conformational changes in inositol trisphosphate receptors.
    Anyatonwu G; Khan MT; Schug ZT; da Fonseca PC; Morris EP; Joseph SK
    J Biol Chem; 2010 Aug; 285(32):25085-93. PubMed ID: 20530483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyr-167/Trp-168 in type 1/3 inositol 1,4,5-trisphosphate receptor mediates functional coupling between ligand binding and channel opening.
    Yamazaki H; Chan J; Ikura M; Michikawa T; Mikoshiba K
    J Biol Chem; 2010 Nov; 285(46):36081-91. PubMed ID: 20813840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of free thiol groups in type-I inositol trisphosphate receptors.
    Joseph SK; Nakao SK; Sukumvanich S
    Biochem J; 2006 Jan; 393(Pt 2):575-82. PubMed ID: 16173918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of functionally critical residues in the channel domain of inositol trisphosphate receptors.
    Bhanumathy C; da Fonseca PC; Morris EP; Joseph SK
    J Biol Chem; 2012 Dec; 287(52):43674-84. PubMed ID: 23086950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural studies of inositol 1,4,5-trisphosphate receptor: coupling ligand binding to channel gating.
    Chan J; Yamazaki H; Ishiyama N; Seo MD; Mal TK; Michikawa T; Mikoshiba K; Ikura M
    J Biol Chem; 2010 Nov; 285(46):36092-9. PubMed ID: 20843799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox regulation of type-I inositol trisphosphate receptors in intact mammalian cells.
    Joseph SK; Young MP; Alzayady K; Yule DI; Ali M; Booth DM; Hajnóczky G
    J Biol Chem; 2018 Nov; 293(45):17464-17476. PubMed ID: 30228182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the inositol 1,4,5-trisphosphate receptor pore-forming segment.
    Schug ZT; da Fonseca PC; Bhanumathy CD; Wagner L; Zhang X; Bailey B; Morris EP; Yule DI; Joseph SK
    J Biol Chem; 2008 Feb; 283(5):2939-48. PubMed ID: 18025085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical regions for activation gating of the inositol 1,4,5-trisphosphate receptor.
    Uchida K; Miyauchi H; Furuichi T; Michikawa T; Mikoshiba K
    J Biol Chem; 2003 May; 278(19):16551-60. PubMed ID: 12621039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaBP1, a neuronal Ca2+ sensor protein, inhibits inositol trisphosphate receptors by clamping intersubunit interactions.
    Li C; Enomoto M; Rossi AM; Seo MD; Rahman T; Stathopulos PB; Taylor CW; Ikura M; Ames JB
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8507-12. PubMed ID: 23650371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IP
    Hamada K; Miyatake H; Terauchi A; Mikoshiba K
    Proc Natl Acad Sci U S A; 2017 May; 114(18):4661-4666. PubMed ID: 28416699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the S4-S5 linker and C-terminal tail in inositol 1,4,5-trisphosphate receptor function.
    Schug ZT; Joseph SK
    J Biol Chem; 2006 Aug; 281(34):24431-40. PubMed ID: 16815846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Competitive Fluorescent Ligand Assay for Inositol 1,4,5-Trisphosphate.
    Tanimura A; Shuto S
    Methods Mol Biol; 2020; 2091():137-144. PubMed ID: 31773577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking structure to function: Recent lessons from inositol 1,4,5-trisphosphate receptor mutagenesis.
    Yule DI; Betzenhauser MJ; Joseph SK
    Cell Calcium; 2010 Jun; 47(6):469-79. PubMed ID: 20510450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and dynamics of the GABA binding pocket: A narrowing cleft that constricts during activation.
    Wagner DA; Czajkowski C
    J Neurosci; 2001 Jan; 21(1):67-74. PubMed ID: 11150321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of the isoform-specific ligand-binding affinity of inositol 1,4,5-trisphosphate receptors.
    Iwai M; Michikawa T; Bosanac I; Ikura M; Mikoshiba K
    J Biol Chem; 2007 Apr; 282(17):12755-64. PubMed ID: 17327232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mechanism in the binding between Homer3 EVH1 domain and inositol 1,4,5 trisphosphate receptor suppressor domain.
    Wen H; Kwon HN; Park S
    Biochem Cell Biol; 2014 Jun; 92(3):163-71. PubMed ID: 24901889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A (beta)-strand in the (gamma)2 subunit lines the benzodiazepine binding site of the GABA A receptor: structural rearrangements detected during channel gating.
    Teissére JA; Czajkowski C
    J Neurosci; 2001 Jul; 21(14):4977-86. PubMed ID: 11438573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted expression of the inositol 1,4,5-triphosphate receptor (IP3R) ligand-binding domain releases Ca2+ via endogenous IP3R channels.
    Várnai P; Balla A; Hunyady L; Balla T
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7859-64. PubMed ID: 15911776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of the Bcl-2/Bcl-X(L)-binding sites on type 1 IP(3) receptor.
    Monaco G; Beckers M; Ivanova H; Missiaen L; Parys JB; De Smedt H; Bultynck G
    Biochem Biophys Res Commun; 2012 Nov; 428(1):31-5. PubMed ID: 23058917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.